Oral Immunotherapy: The Future of Peanut Allergy Management

peanut allergy treatment

“Don’t eat peanuts or you’ll die!”

For decades, strict avoidance was our approach to peanut allergy management. If you never ate peanuts, you would never react. 

But unfortunately, life is unpredictable, and accidental ingestion happens all the time. 

The Limitations of Strict Avoidance

Even the most careful parents can’t control every meal their child eats. 

Schools, restaurants, social gatherings—anywhere food is served—are potential minefields. If you have no desensitization because of avoidance, your allergic reaction can be very severe, leading often to anaphylaxis. 

Young adults (ages 18-25) are particularly vulnerable to this.

They don’t always double-check ingredient lists from the grocery store because they’ve been buying that product for years (which companies change frequently without notice). And because they eat out more often, they’re at greater risk of accidentally ingesting peanuts used to make sauces thicker that the waiter has no idea about and is not listed on the menu.

Even if avoidance is successful, it doesn’t treat the allergy and creates a deep-rooted fear of food exposure, increasing anxiety for both patients and their families.

Thankfully, oral immunotherapy (OIT) is changing that.

Why OIT’s Benefits Outweigh the Risks

Instead of avoiding allergens, OIT has patients consume controlled, increasing doses to desensitize their immune system. 

The goal isn’t just to prevent anaphylaxis, but to make life normal again. So far, the four major foods you can achieve desensitization with are peanuts, milk, eggs, and tree nuts. This treatment has been slowly introduced within the last 10 years, and more foods are being studied now.

Here’s what OIT does that avoidance never could:

  • Builds tolerance – Patients reach a level where accidental ingestion won’t trigger a severe reaction. Many can eat small amounts of peanuts without issue.
  • Reduces anxiety – No more living in fear of every meal, every snack, every cross-contaminated kitchen counter.
  • Prevents hospitalizations – One emergency room visit for anaphylaxis can cost upwards of $50,000. OIT drastically lowers that risk.

The process takes time, typically six months to reach a protective level of tolerance against anaphylaxis.

Patients as young as 3 years old start with a microdose, gradually increasing every two weeks under medical supervision. By the end, they’re consuming at least 300mg of peanut protein (about one peanut’s worth). Many continue increasing their dose, reaching levels that allow them to eat peanuts freely.

Clinical trials are showing OIT has a success rate of 70-80%, while sublingual immunotherapy (placing peanut extract under the tongue) offers a safer but slightly less effective alternative with a 60-70% success rate.

A systematic review and meta-analysis by Riggioni et al. found that OIT significantly increased the likelihood of achieving tolerance compared to avoidance or placebo. In particular, peanut OIT had a relative risk (RR) of 11.94, meaning patients undergoing OIT were nearly 12 times more likely to develop tolerance compared to those avoiding peanuts. 

Another systematic review by Brożek et al. confirmed that OIT for cow’s milk allergy increased the likelihood of achieving full tolerance with an RR of 10.0, showing clear advantages over elimination diets.

Although OIT can lead to mouth itching, gastrointestinal side effects, and some serious reactions like mild laryngospasm or anaphylaxis requiring epinephrine during treatment, strict avoidance offers 0% protection if accidental exposure happens. 

That’s the real risk.

How to Implement OIT in an Allergy Clinic

Despite its proven effectiveness, OIT isn’t available in every allergy office.

There is a lack of education, fear of reactions, and staffing limitations because it typically takes a couple of hours per OIT dosing. But integrating OIT isn’t as complex as it seems.

Here’s how we can change that:

  1. Allergists need proper training – National organizations like the AAAI and ACAI now offer half-day courses on food desensitization. This field is changing rapidly, and little snippets online are not enough to know how to perform OIT safely and effectively.
  2. Find a mentor – Clinics like mine already offering OIT can guide new providers through the process.
  3. Ensure adequate staffing – OIT requires close monitoring, particularly on dose-escalation days. Clinics need nurses trained in recognizing early reaction symptoms and managing dose adjustments.

At the very least, we can get started desensitizing patients from peanuts, milk, eggs, and tree nuts. There are plenty of safe OIT escalation ladders and standard procedures to follow, and more will be developed for the other allergens.

What Happens If We Desensitize More Patients?

If more allergists embrace OIT, the impact on public health will be enormous.

When somebody successfully gets desensitized, their anxiety (and their family’s) takes a nosedive. So many families worry all the time about accidental ingestion, putting a toll on their mental health. But now, OIT relieves that by building up tolerance to allergens and reducing anaphylaxis, giving families a freedom they haven’t felt in years.

The healthcare system also benefits, because increased tolerance means fewer $50,000 hospital visits, saving millions.

I want to stress this isn’t just about peanuts, but about changing the entire approach to food allergies. The medical community has been reacting to allergies for decades. It’s time to start preventing them instead.

Strict avoidance is outdated. OIT is the future.

If you have any questions about OIT, ask away in the comments below.